US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

INVO

INVO BioScience (INVO)

INVO BioScience Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INVO

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
24/10/2024	08:00	GlobeNewswire Inc.	NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma	NASDAQ:INVO	INVO BioScience Inc
22/10/2024	11:05	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:INVO	INVO BioScience Inc
21/10/2024	08:00	GlobeNewswire Inc.	INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences	NASDAQ:INVO	INVO BioScience Inc
15/10/2024	08:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INVO	INVO BioScience Inc
14/10/2024	08:18	GlobeNewswire Inc.	INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)	NASDAQ:INVO	INVO BioScience Inc
14/08/2024	08:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INVO	INVO BioScience Inc
14/08/2024	08:00	GlobeNewswire Inc.	INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA	NASDAQ:INVO	INVO BioScience Inc
21/05/2024	15:39	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:INVO	INVO BioScience Inc
15/05/2024	15:15	GlobeNewswire Inc.	INVO Reports Record First Quarter 2024 Financial Results	NASDAQ:INVO	INVO BioScience Inc
17/04/2024	09:25	AllPennyStocks.com	Micro Cap Massively Bid Up Before Opening Bell	NASDAQ:INVO	INVO BioScience Inc
16/04/2024	15:59	GlobeNewswire Inc.	INVO Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:INVO	INVO BioScience Inc
06/02/2024	09:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INVO	INVO BioScience Inc
23/01/2024	07:00	GlobeNewswire Inc.	NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)	NASDAQ:INVO	INVO BioScience Inc
17/01/2024	07:00	GlobeNewswire Inc.	INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors	NASDAQ:INVO	INVO BioScience Inc
16/01/2024	16:29	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:INVO	INVO BioScience Inc
10/01/2024	15:46	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:INVO	INVO BioScience Inc
28/12/2023	16:04	Edgar (US Regulatory)	Form 424B7 - Prospectus [Rule 424(b)(7)]	NASDAQ:INVO	INVO BioScience Inc
13/12/2023	16:08	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INVO	INVO BioScience Inc
11/12/2023	07:00	PR Newswire (US)	NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal	NASDAQ:INVO	INVO BioScience Inc
28/11/2023	08:00	PR Newswire (US)	INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement	NASDAQ:INVO	INVO BioScience Inc
24/11/2023	12:08	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:INVO	INVO BioScience Inc
13/11/2023	15:01	PR Newswire (US)	INVO Reports Record Third Quarter 2023 Financial Results	NASDAQ:INVO	INVO BioScience Inc
13/11/2023	08:23	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:INVO	INVO BioScience Inc
13/11/2023	08:12	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:INVO	INVO BioScience Inc
10/11/2023	08:00	PR Newswire (US)	NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger	NASDAQ:INVO	INVO BioScience Inc
09/11/2023	15:40	PR Newswire (US)	INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants	NASDAQ:INVO	INVO BioScience Inc
27/10/2023	08:00	PR Newswire (US)	Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023	NASDAQ:INVO	INVO BioScience Inc
23/10/2023	06:30	PR Newswire (US)	INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company	NASDAQ:INVO	INVO BioScience Inc
11/10/2023	08:00	PR Newswire (US)	INVO to Participate in the Lytham Partners Fall 2023 Investor Conference	NASDAQ:INVO	INVO BioScience Inc
29/09/2023	15:05	PR Newswire (US)	INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS	NASDAQ:INVO	INVO BioScience Inc

Showing the most relevant articles for your search:NASDAQ:INVO

1 2 3 4 5 Próxima >

Health Care Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones